US-Guided Quadro-Iliac Plane Block for Postoperative Analgesia After Lumbar Instrumentation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBursa City Hospital

About this trial

Lumbar instrumentation surgery is associated with significant postoperative pain. This study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane Block in patients undergoing lumbar instrumentation surgery, aiming to assess the efficacy of this newly developed technique for postoperative pain management.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Classified as American Society of Anesthesiologists (ASA) physical status I-III

Scheduled for elective lumbar instrumentation surgery

Surgery performed under general anesthesia

Provision of written informed consent

Disqualifiers

Use of anticoagulant or antiplatelet medications

Presence of bleeding diathesis or coagulation disorders

Known allergy or hypersensitivity to local anesthetics or opioid medications

Infection at the planned block site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Quadro-Iliac Plane Block

    Procedure/Surgery

    Ultrasound-guided regional anesthesia technique performed between the erector spinae muscle and the quadratus lumborum muscle at the iliac crest level.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Group QIPBActive comparator 1 intervention
Group B: Group ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Postoperative 48-Hour PCA Opioid Consumption

Total amount of opioid delivered by the patient-controlled analgesia (PCA) device during the first 48 hours after surgery, recorded in milligrams (mg).

Time frame
Postoperative 0-8, 8-16, 16-24, 24-48 intervals
2

QoR-15 Recovery Score

The investigators will use the Turkish version of Quality of Recovery (QoR) / QoR-15 questionairre PART A How have you been feeling in the last 24 hours? (0 to 10, where: 0 = none of the time \[poor\] and 10 = all of the time \[excellent\]) Able to breathe easily Been able to enjoy food Feeling rested Have had a good sleep Able to look after personal toilet and hygiene unaided Able to communicate with Getting support from hospital doctors and nurses Able to return to work or usual home activities Feeling comfortable and in control Having a feeling of general well-being PART B Have you had any of the following in the last 24 hours? (10 to 0, where: 10 = none of the time \[excellent\] and 0 = all of the time \[poor\]) Moderate pain Severe pain Nausea or vomiting Feeling worried or anxious Feeling sad or depressed

Time frame
Postoperative 24th and 48th hours

Secondary outcomes

1

Dynamic and static NRS scores

Numeric Rating Scale (NRS) (0-10) pain scores at rest or movement at predefined postoperative hours

Time frame
0, 2, 4, 8, 16, 24, and 48 hours postoperatively
2

Total rescue analgesic dose

Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered as rescue analgesia. Total amount of meperidin during the first 24 and 48 hours after surgery, recorded in milligrams (mg).

Time frame
Postoperative 24th and 48th hours
3

Time of first request for rescue analgesia

Despite the use of patient-controlled analgesia (PCA), if the Numeric Rating Scale (NRS) score is ≥4 at any time point, 0.5 mg/kg intravenous meperidine will be administered as rescue analgesia.

Time frame
Postoperative 48-Hours
4

Length of Hospital Stay

Length of hospital stay will be defined as the number of days from the end of surgery to hospital discharge.

Time frame
Patients will remain under observation for at least 2 weeks until their postoperative discharge. Follow-up will be completed upon discharge. The length of hospital stay will be recorded (day).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.